Filter Results:
(54)
Show Results For
- All HBS Web
(637)
- People (2)
- News (54)
- Research (449)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Show Results For
- All HBS Web
(637)
- People (2)
- News (54)
- Research (449)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Page 1 of 54
Results →
Sort by
- 07 Apr 2016
- News
Sanofi Genzyme Donates Corporate Archives to Harvard Business School
- 03 Aug 2010
- News
Analysis: Rare diseases lure Sanofi, other big drugmakers
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 03 Dec 2012
- News
In World of Big Stuff, the U.S. Still Rules
- 04 Jun 2010
- News
Another View: Can Biotech Survive Icahn?
- 08 Jan 2018
- News
What Do Investors and Companies Talk About?
- 31 Jan 2014
- News
Body, Heal Thyself
Chien and Derrick Rossi, published a paper in the journal Nature Biotechnology that showed mRNA Therapeutics was capable of stimulating blood vessel growth, repairing damaged heart tissue, and helping a mouse through myocardial... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
focused on patients. “Patients and their families are at the center of why I want to be in the biotechnology space,” she concludes. “When you’re working on rare diseases, it’s hard not to feel like you’re making a difference.” View Details
- 01 Aug 1998
- News
High Honors
education." McDermott hasn't slowed down in retirement, concentrating his energy and vision on an array of community-related projects. Among them is the Texas Research and Technology Foundation, which he established in 1984 to develop San Antonio's Texas Research Park,... View Details
- 01 Jun 1998
- News
Short Takes
inextricably intertwined with institutions that are inherently local," he writes. He intends to test his findings by investigating process innovation in companies entering the semiconductor industry from Europe and Asia. He also plans to conduct a similar study of... View Details
Keywords: Orna Feldman and Caroline Chauncey
- 01 Feb 1999
- News
Classmates Rally to Help Family Stricken with Rare Disease
scientists and researchers, in conjunction with several biotechnology companies, including Genzyme Corp., are now ready to test on humans an enzyme replacement therapy that has been successful in reversing the disease in laboratory... View Details
- 01 Mar 2019
- News
The Blue-Green Revolution
engineering algae to get fat without going comatose. As a result, “You can take the brakes off oil formation without putting the brakes on growth,” says SGI’s CEO, Oliver Fetzer. In a study published in Nature Biotechnology in 2017, SGI... View Details
- 01 Dec 1996
- News
Entrepreneurship at HBS
direct marketing, consumer products, and consulting. Following Professor Georges F. Doriot's lead, our graduates have had a major impact on the venture capital industry, which in turn financed a revolution in semiconductors, personal computers, communications, and... View Details
- 01 Dec 2004
- News
The Future of Stem Cells
sickle cell anemia.) A board member and former chair of the Massachusetts Biotechnology Council, Fisher says states are stepping up to fund stem-cell work, partly in response to their constituents who want the jobs and businesses — as... View Details
Keywords: Garry Emmons
- 23 Jan 2019
- News
The Promise of Personalized Medicine
as a biotechnology company, Myofinity Biosciences. Those two organizations have taken two different paths. They’re not connected. The 501(c)(3), Terry’s Foundation (now Cure Rare Disease), is doing something incredibly unprecedented. What... View Details
- 01 Feb 1997
- News
Made, Not Born: HBS Courses and Entrepreneurial Management
students to focus on what interests them. As part of their projects, they can evaluate new business ideas, prepare business plans, or consult with existing entrepreneurial businesses. One team of students, for example, worked with a fast-growing View Details
- 01 Mar 2011
- News
Making Their Way
Station, and even the White House. Like most family businesses, there are plenty of stories in the Kirlin Company’s history, including Brownell’s own. After graduating from HBS, she and her husband, HBS classmate Stephen Brownell, moved to Los Angeles where she worked... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details